Jul 6, 2026
June 2026: Loma Therapeutics Receives Second Innobooster We are honored to have received a second Innobooster grant The grant totals 5.000.000 DKK (~€670.000), which will advance the development of Loma’s novel HPV-targeted immunotherapy that holds the...
Jun 26, 2025
June 2025: Loma Therapeutics Receives Large Grant We are thrilled that we have received the prestigious Grand Solutions Grant. The project partners, consisting of Loma Therapeutics, the Technical University of Denmark, and the Kingdom Hospital of Denmark, will...
Feb 14, 2025
February 2025: Loma announces Board of Directors. We are thrilled to announce that a board of directors has been established, reflecting the growth and further development of Loma. The board of directors of Loma comprises: Chair Alejandra Mørk: Alejandra has over...
Nov 25, 2024
OCTOBER 2024: Loma engages with key stakeholders in Kenya. We are thrilled to share highlights from our recent visit to Kenya, where our team had the privilege of meeting with influential local stakeholders to discuss our work on developing a therapeutic vaccine for...
Nov 25, 2024
SEPTEMBER 2024: Loma presents at Nordic Life Science Days 2024. Loma participated in Nordic Life Science (NLS) Days 2024, where we had the opportunity to present our pioneering work on developing a therapeutic vaccine against HPV+ cancers. Engaging with life science...
Nov 25, 2024
SEPTEMBER 2024: Loma joins the Venture House Program at BII. We are thrilled to announce that Loma has been selected to join the Venture House program at the BioInnovation Institute (BII)! This opportunity marks a significant milestone in our mission to develop the...
